Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Short Candidates -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (646)	4/23/2004 7:46:47 AM
From: IRWIN JAMES FRANKEL	Read Replies (1) \| Respond to of 897

ONXX - Friedman Billings initiated coverage as outperform yesterday with a 61 price target. I'm short. ij

To: Miljenko Zuanic who wrote (646)	5/5/2004 2:31:39 PM
From: tuck	Read Replies (2) \| Respond to of 897

Per my posting on the Diabetes thread, I now include NKTR on the WatchList, and am tempted to start right now. Message 20096039 I welcome thoughts on the matter. On another front, ONXX looking a bit frisky again, and I'm looking for reentry point there. And finally, I need to see how Project BioShield is doing, and how much VXGN might benefit. I've managed to stay away and not get burned, but it's looking a little pricey again. Other candidates are always welcome. Summer's coming; time to do our DD! Cheers, Tuck